Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
International Journal of Molecular Sciences
|
November 27, 2024
ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma
Domenico Mallardo, Mario Fordellone, Margaret Ottaviano, et al.
Journal of Translational Medicine
|
November 5, 2017
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy
Giuseppe V Masucci, Alessandra Cesano, Alexander Eggermont, et al.
Blood Advances
|
June 29, 2022
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
Valentina Tabanelli, Federica Melle, Giovanna Motta, et al.
Haematologica
|
November 13, 2012
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies
Alessandra Cesano, Omar Perbellini, Erik Evensen, et al.
Journal of Translational Medicine
|
November 8, 2021
Contextual reprogramming of CAR-T cells for treatment of HER2<sup>+</sup> cancers
Zhifen Yang, Lingyu Li, Ahu Turkoz, et al.
Plos One
|
April 18, 2015
Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia
Alessandra Cesano, Cheryl L Willman, Kenneth J Kopecky, et al.
Journal for Immunotherapy of Cancer
|
July 9, 2025
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma
Domenico Mallardo, Mario Fordellone, Michael Bailey, et al.
Journal of Translational Medicine
|
November 6, 2019
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
Diane Damotte, Sarah Warren, Jennifer Arrondeau, et al.
Journal for Immunotherapy of Cancer
|
January 17, 2025
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review
Alessandra Cesano, Ryan Augustin, Luigi Barrea, et al.
Journal for Immunotherapy of Cancer
|
June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriers
James L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
International Journal of Molecular Sciences
|
November 27, 2024
ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma
Domenico Mallardo, Mario Fordellone, Margaret Ottaviano, et al.
Journal of Translational Medicine
|
November 5, 2017
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy
Giuseppe V Masucci, Alessandra Cesano, Alexander Eggermont, et al.
Blood Advances
|
June 29, 2022
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
Valentina Tabanelli, Federica Melle, Giovanna Motta, et al.
Haematologica
|
November 13, 2012
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies
Alessandra Cesano, Omar Perbellini, Erik Evensen, et al.
Journal of Translational Medicine
|
November 8, 2021
Contextual reprogramming of CAR-T cells for treatment of HER2<sup>+</sup> cancers
Zhifen Yang, Lingyu Li, Ahu Turkoz, et al.
Plos One
|
April 18, 2015
Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia
Alessandra Cesano, Cheryl L Willman, Kenneth J Kopecky, et al.
Journal for Immunotherapy of Cancer
|
July 9, 2025
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma
Domenico Mallardo, Mario Fordellone, Michael Bailey, et al.
Journal of Translational Medicine
|
November 6, 2019
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
Diane Damotte, Sarah Warren, Jennifer Arrondeau, et al.
Journal for Immunotherapy of Cancer
|
January 17, 2025
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review
Alessandra Cesano, Ryan Augustin, Luigi Barrea, et al.
Journal for Immunotherapy of Cancer
|
June 28, 2017
Immunotherapy biomarkers 2016: overcoming the barriers
James L Gulley, Jay A Berzofsky, Marcus O Butler, et al.
Page
of 9